Q32 Bio Inc.
QTTBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $158.06M
- P/E (TTM)
- 4.68
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.91$23.57
- Volume (live)
- -
- Avg. volume (3M)
- 1.04M
Q32 Bio (QTTB) Stock Price & Financial Analysis
Q32 Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.28 - $7.82 |
|---|---|
| 52-Week High | $23.57 |
| 52-Week Low | $1.91 |
| Open | $7.82 |
| Volume (last close) | 678.00K |
| Average Volume (3M) | 1.04M |
| Revenue (TTM) | 53.74M |
|---|---|
| Net Income (TTM) | 33.79M |
| Free Cash Flow (TTM) | -19.83M |
| EPS (TTM) | $2.26 |
| Profit Margin | 62.87% |
| Operating Margin | 39.94% |
| Return on Equity (ROE) | 31.90% |
| Debt to Equity | 0.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 158.06M |
|---|---|
| Shares Outstanding | 20.34M |
| P/E Ratio (TTM) | 4.68 |
| Price to Sales (P/S) | 2.94 |
| Price to Book (P/B) | 1.49 |
| EV/EBITDA | 1.66 |
| 50-Day MA | $12.17 |
|---|---|
| 200-Day MA | $8.93 |
| 1-Year Change | +145.11% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Q32 Bio at a Glance
As of the Oct 16, 2026 close, Q32 Bio (QTTB) has a market capitalization of $158.06M. The stock trades at 4.7× trailing earnings and 2.9× sales. Over the trailing twelve months it earned $33.79M on revenue of $53.74M (a 62.9% profit margin) and burned $19.83M of free cash flow.
As of its latest reported balance sheet, it holds $106.27M in cash and securities against $5.30M of debt, a net cash position of $100.97M.
Q32 Bio does not currently pay a dividend.
The share price is up 145.1% over the past year. At $7.52 (the Oct 16, 2026 close) it sits within its 52-week range of $1.91 to $23.57, below its 200-day moving average of $8.93.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $39.33, 423.0% above the Oct 16, 2026 close.
Frequently Asked Questions About Q32 Bio
What is the current stock price for QTTB?
As of the Oct 16, 2026 close, QTTB stock trades at $7.52. The 52-week range is $1.91–$23.57, with a day range of $7.28–$7.82.
What is the P/E ratio for QTTB?
As of the Oct 16, 2026 close, Q32 Bio's trailing twelve-month (TTM) P/E ratio is 4.7, meaning investors pay $4.7 for every $1 of annual earnings. Q32 Bio operates in the Healthcare sector.
Does QTTB pay dividends?
Q32 Bio does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for QTTB?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for QTTB is Buy. The average 12-month price target is $39.33, a 423.0% upside from the Oct 16, 2026 close of $7.52.
What is the market cap of QTTB?
As of the Oct 16, 2026 close, Q32 Bio's market capitalization is $153.0M, classifying it as a micro-cap company. Q32 Bio operates in the Healthcare sector within the Biotechnology industry.